Solar simplified
Alpha Ventus wind turbines in the North Sea
Offshore turbine - 3D presentation
MISTRAL 20-600 kVA Fuel cell Backup power system
Gilles, Civil Engineering Referent
Jean-Christophe, Mechanical Calculation Engineer
Emmanuelle, Solar R&D Program Manager
Solutions for nuclear and renewable power generation (english only)
"AREVA at a glance" brochure
Report on diversity 2010
About AREVA Med
AREVA Med is an AREVA subsidiary based in Bethesda, Maryland, United States.
The company is contributing to the fight against cancer by developing innovative methods to produce the rare radioisotope 212Pb.
It is used in alpha radioimmunotherapy, a promising treatment to fight, notably, pancreatic, ovarian, colon, breast, prostate and other cancers.
A critical mission
AREVA Med has a dual mission: to industrialize production of 212Pb and to develop innovative and powerful therapies to combat deadly diseases.
The TAO project
A team working at La Hague came up with the idea of extracting 212Pb from AREVA’s industrial activities.
Organization
The company relies on the expertise of the AREVA group, as well as leading international experts and research institutions.
AREVA Med milestones
Since its creation, AREVA Med has achieved a number of important milestones.
